Regression models for NMI- and NuMIT-normalised (a) synergies and (b) redundancies between and MMI PID definitions, for LSD, ketamine, and psilocybin drugs.
Alberto Liardi (22305679), Fernando E. Rosas (9595503), Robin L. Carhart-Harris (5923571), George Blackburne (22305682), Daniel Bor (297008), Pedro A. M. Mediano (5786234)
OPAL (Open@LaTrobe) (La Trobe University) November 5, 2025 DOI: 10.1371/journal.pcbi.1013629.g005 via OpenAlex
Summary
AI-generated from the abstractThe abstract discusses differences between drug and placebo conditions in terms of partial information decomposition (PID) atoms, using two specific PID methods: MMI and CCS. It focuses on how these methods quantify unique and redundant information contributions in a system, likely in the context of neural or cognitive data. The text is too brief to convey a complete finding or argument.
Study at a glance
| Characteristics | Peer reviewed |
|---|---|
| Topics | Psilocybin |
| Keywords | Pid controller Control theory sociology Computer science Artificial intelligence Regression analysis |
Abstract
Δ indicates the differences between drug and placebo in PID atoms obtained with either PID (MMI or CCS).